Susan Cleary

TL;DR: In this paper, the authors presented baseline cost-effectiveness data from one of the longest running public healthcare antiretroviral treatment programmes in Africa that could assist in enhancing efficient resource allocation and equitable access to HIV treatment.

TL;DR: It is important to limit the potential negative impacts on responsiveness of new bureaucratic accountability mechanisms, and identify how these or other interventions might leverage the shifts in organizational culture necessary to encourage innovation and patient-centered care.

TL;DR: HAART is reasonably cost-effective for HIV-infected patients in South Africa, and most effective if initiated if initiated when CD4 count >200/microl, but this should be balanced against the significant clinical benefits associated with early therapy.

TL;DR: It is suggested that everyday resilience seems to arise from the leadership offered by multiple managers, through a combination of strategies that become embedded in relationships and managerial routines, drawing on wider organisational capacities and resources.

TL;DR: The aims of this study were to identify points in patient pathways from start of TB symptoms to treatment completion where interventions could be targeted to reduce the economic impact on patients and households, and to identify those most vulnerable to these costs.